Across European nations, the administration of ketamine for psychiatric conditions is seeing a significant rise. Primarily employed as an anesthetic, ketamine's promise as a therapy for depression , particularly treatment-resistant forms, has sparked considerable exploration among clinicians . While regulations vary widely from country to nation